Masimo CEO Joe Kiani pledged $400 million in Masimo stock for loans
Founder and CEO of Masimo, Joe Kiani addresses a press conference in Bangalore on January 2, 2017. Manjunath Kiran | Afp | Getty Images Billionaire Masimo founder Joe Kiani, best…
2024-05-14 04:14:07
Founder and CEO of Masimo, Joe Kiani addresses a press conference in Bangalore on January 2, 2017. Manjunath Kiran | Afp | Getty Images Billionaire Masimo founder Joe Kiani, best…
Walking the party plank Ed Rollins, a forever strategist, possibly starting with Thomas Jefferson, says: “Politics needs strategy. An old boxer, I don’t intimidate easily. First, analyze your candidate. Anticipate…
Jamie Dimon, CEO of America’s largest bank JP Morgan Chase, has been iced out of the White House’s good graces after apparently endorsing Republican policies and calling Donald Trump “kind…
Bill Ackman, Pershing Square Capital Management CEO, speaking at the Delivering Alpha conference in New York City on Sept. 28, 2023. Adam Jeffery | CNBC Pershing Square’s Bill Ackman is…
Business Insider’s top executive and parent company said Sunday they were satisfied with the fairness and accuracy of stories that made plagiarism accusations against a former MIT professor who is…
So now it’s one president down, no more to go. The decision by Harvard pooh-bahs to keep Claudine Gay was predictable but still disappointing. It sucks some of the air…
I hate CEO virtue-signaling. It’s often so fake and it leads to perverse outcomes. Yet if there was ever a time to indulge in it, now would be the time…
Elon Musk (L) and Bill Ackman Reuters (L) | CNBC (R) Activist investor Bill Ackman on Monday told CNBC he had not spoken with Elon Musk about a deal involving…
Bill Ackman, founder and CEO of Pershing Square Capital Management. Adam Jeffery | CNBC Billionaire hedge fund chief Bill Ackman donated $3,300 in the second quarter to Democrat and anti-vaccine…
Bill Ackman twisted the knife into old rival Carl Icahn on Wednesday with a broadside attack that questioned the valuation of the famed activist investor’s flagship firm, whose company has…